Leaflet OMNIPAQUE 240mg I/ml 240mg I / ml solution for injection
Indicated for: diagnostic imaging contrast enhancement
Route of administration: injectable
Substance: iohexol (contrast agent)
ATC: V08AB02 (Various | X-ray contrast media, iodinated | Watersoluble, nephrotropic, low osmolar x-ray contrast media)
Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.
This medicine is subject to additional monitoring.
This medicine may affect the kidneys.
Iohexol is a contrast agent used in medical imaging, including computed tomography (CT) and angiography. It helps visualize internal structures by enhancing the contrast between different tissues.
The medication is administered intravenously or intrathecally, as directed by a doctor. It is important to monitor the patient for adverse reactions during the procedure.
Side effects may include nausea, vomiting, a sensation of warmth, or allergic reactions. In rare cases, severe reactions such as anaphylactic shock or renal failure may occur.
Iohexol is not recommended for patients with hypersensitivity to iodinated contrast agents or severe renal impairment.
General data about OMNIPAQUE 240mg I/ml 240mg I / ml
- Substance: iohexol
- Date of latest medicines list: 01-07-2013
- Product code: W07800004
- Concentration: 240mg I / ml
- Pharmaceutical form: solution for injection
- Packing volume: 50 ml
- Product type: Original
- Prescription status: S - Medicines dispensed with a restricted medical prescription, reserved for use in certain specialized fields.
Concentrations available for iohexol
- 240mg I /ml
- 300mg I /ml
- 350mg I /ml